Top 10 Angel Investors in Isle of Man in September 2025

Last updated: Sep 2025 A list of 10 angel investors that invest in startups based in Isle of man. We rank investors based on the number of investments they made in companies from Isle of man. We update this investor list every month.

Top 10 Angel Investors in Isle of Man in September 2025

Investor	Isle of Man investments
Chris Adelsbach	1
Jim Mellon	1
Paolo Rubatto	1
Stuart Gardner	1
Will Neale	1
Greg Bailey	1
Charles Delingpole	1
James Isilay	1
Tom James	1
Wendy O	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Chris Adelsbach - Founding Partner @ Outrun Ventures

Investment focus

FinTech, Financial Services, Software
Seed, Pre-Seed, Series A
United Kingdom, United States, Ireland

Portfolio highlights

Bourn — Bourn's technology is designed to automate cash flow management, offering SMEs fast access to capital.
Alfa AI — Alfa AI is a recruitment technology company specializing in AI-driven hiring solutions.
Cloud Capital — CloudCapital manages cloud costs and invests in tech companies using AI and ML.

Jim Mellon is an international investor with interests in several industries. After leaving Oxford, where he studied PPE, (Philosophy, Politics and Economics) he worked in Asia and the United States for two fund management companies, GT and Thornton, before establishing his own business in 1991. His business operations include two components, alisted fund management company called Charlemagne Capital, and an Asian mining group, Regent Pacific.In addition, Mr. Mellon is Co-Chairman of West African Minerals Corporation and Regent Pacific Group. He is on the board of a number of public quoted companies, including Brazilian Gold Corporation, Charlemagne Capital Limited, Manx Financial Group, Plethora Solutions, Polo Resources, Port Erin Biophara Investments Limited, and the Speymill plc. He is the life tenant of a trust which owns the Burnbrae Group, which has substantial assets in the biotechnology, financial services, property, mining and leisure sectors. Mr. Mellon spends most of his time working on startup ideas and investing. His book, “Wake Up!” was published in 2005; his second book "10 Investments for the Ten Years Ahead" was published in 2008. In 2012, he co-wrote "Cracking the Code" which focuses on the biotechnology sector and how to profit from it. Mr. Mellon lives in the Isle of Man, Brussels and Ibiza and is an honorary fellow of Oriel College, Oxford.

Investment focus

Biotechnology, Food and Beverage, Health Care
Series A, Seed, Funding Round
United States, United Kingdom, Germany

Portfolio highlights

Voxia — Amy collects and analyzes information from all over the web and provides actionable insights about your leads, prospects and clients, all in one click.
Monaco Foundry — We are a team of Serial Entrepreneurs, former Senior Government Advisors and Fortune 500 Executives. A global venture accelerator that invests in early to mid-stage companies and their growth through a unique sweat equity model.
The Duppy Share — The Duppy Share Caribbean Rum is the best rum for cocktails, mixed drinks and rum gifts. Try all our rum recipes, from rum and ginger to dark rum punch.

Paolo Rubatto is Managing Director of Start Capital. His background is mainly entrepreneurial, advising startups from the consumer internet to the life sciences sector in their business development strategies as well as in their fundraising. He holds an MBA from London Business School.

Investment focus

Software, Big Data, E-Commerce
Seed, Pre-Seed, Series A
United States, United Kingdom, India

Portfolio highlights

SAPI — SAPI builds credit products for payment companies to facilitate payment flows, engage and retain merchants, and generate new revenue.
Coindirect — BVNK is a next-generation payments platform. We're making payments as accessible and resilient as the internet.
Kosmik — Transform your creative workflow with Kosmik's AI moodboard maker. Built-in browser, auto-tagging, and infinite canvas for seamless visual research.

Stuart Gardner

Investment focus

Financial Services, Funding Platform, Solar
Pre-Seed, Seed, Angel
United Kingdom, United States, Isle of Man

Portfolio highlights

Fundably — Fundably - Get The Right UK Business Loan | Access £1k-£2m
MONET — Embedded finance for agencies and B2B platforms. Frictionless access to white-labelling B2B credit, global payments and new revenue streams. Offer white-label invoice finance to your network, driving growth for you and your suppliers.
VIAN Therapeutics — VIAN Therapeutics is an early-stage biotechnology company focused on transforming retinal disease treatment. With a first-in-class, non-invasive eyedrop as its lead product, VIAN aims to replace invasive injections for conditions like age-related macular degeneration (AMD) and diabetic macular edema (DME). Backed by strong preclinical data andongoing clinical testing, VIAN is positioned to address significant unmet medical needs and disrupt the $15 billion retinal disease market.

Founder (Grabyo, Fonix). Investor.

Investment focus

FinTech, Financial Services, Software
Seed, Pre-Seed, Funding Round
United Kingdom, Italy, Japan

Portfolio highlights

qomodo — Qomodo: La piattaforma BNPL innovativa. Rate a tasso zero, approvazioni veloci, transazioni sicure. Rivoluzionaria nell'acquisto per aziende e consumatori.
Verisian — Verisian accelerates drug time to market with the industry's first platform offering real study traceability (CDISC, SDTM, ADaM, TFLs)
SAPI — SAPI builds credit products for payment companies to facilitate payment flows, engage and retain merchants, and generate new revenue.

Dr. Gregory H. Bailey is a Managing Partner at Palantir Group, Inc. Dr. Bailey is the Co-founder of Ascent Healthcare Solutions; VirnetX Inc. (AMEX:VHC) and Duramedic Inc. He was also the initial public financier and an independent director of Medivation, Inc. (NASDAQ:MDVN), from 2005 to December 2012. Dr. Bailey served as the Managing Director andco-Head of Life Sciences at MDB Capital Group LLC from May 2004 to January 2007. Previously he served as Life Sciences Analyst at Participating Capital, Corp. He has served on the board of directors of multiple public companies. Dr. Bailey has Medical Doctorate from the University of Western Ontario and practiced medicine as an emergency physician for ten years.

Investment focus

Biotechnology, Pharmaceutical, Medical
Series A, Seed, Funding Round
United States, Isle of Man

Portfolio highlights

Juvenescence — We extend healthy lifespan through developing innovative medicines that target core aging mechanisms to not only treat but prevent age-related diseases.
Bristol-Myers Squibb — Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.
Biohaven Pharmaceutical — Biohaven is a clinical-stage biopharmaceutical company. It has a portfolio of late-stage product candidates targeting neurological diseases, including rare disorders. The company product candidates are based on multiple mechanisms-calcitonin gene-related peptide receptor antagonists, glutamate modulators and myeloperoxidase inhibitor. Its pipelineproducts include BHV3000-301, BHV3000-302, BHV3000-303, and others.

Charles Delingpole is Founder and CEO of ComplyAdvantage, a technology company focused on wiping out financial crime using Machine Learning. As CEO, Charles leads the product development and growth of the company. His passion for the issue came from his time as the MLRO of a previous startup he founded when he realized how inefficient processesaround money laundering are. Charles previously worked at The Student Room as a Founder and CEO. He attended the University of Cambridge and The London School of Economics and Political Science (LSE).Over 99% of money laundering is successful, ComplyAdvantage is working to stop it completely. Founded in 2014 with offices in London, New York, Singapore, and Cluj, ComplyAdvantage work with over 350 firms across 45 countries. Charles set up his first company, The Student Room Group, now the world’s largest student discussion forum when he was 16. After completing his MA in Politics at Trinity College Cambridge, and then an MSc in Management, Strategy, and Finance from the LSE, he became an associate at J.P. Morgan Cazenove.